A 24-year-old man with livedo racemosa and psychiatric disturbances, manifesting as low intelligence (IQ 80) However, a low dose of haloperidol is still necessary to maintain his mental condition. (Internal Medicine 35: 668-673, 1996) 
Introduction
Livedo racemosa is a cutaneous condition resulting from an irregular, focal, and persistent impairment of the blood flow due to atherosclerosis or vasculitides. The association between livedo racemosa and cerebrovascular manifestation was first describedby Kimming (1) in 1959. Champion andRock (2) and Church (3) also reported similar cases. In 1965, Sneddon (4) described six patients with this combination including Church 's case. He speculated that this disorder was a type ofendoarteritis obliterans. Subsequently, this combination came to be known as Sneddon's syndrome because there are no signs of polyarteritis nodosa, systemic lupus erythematosus, rheumatoid arthritis, or other definite systemic diseases. Regarding the pathogenesis of this syndrome, the importance of anti-phospholipid antibodies has been emphasized. However, the incidence of positive anti-phospholipid antibodies in conventional methods varies from 20% (5) to almost 60% (6) . Other factors may also induce Sneddon's syndrome. The incidence of this syndrome has been estimated at 0.26% of the total cerebrovascular disease cases (7) . Although more than one hundred cases have been reported over the world, we could find only three previous cases reported in Japan (8) (9) (10) . Here, we report a case of Sneddon's syndrome in which the patient has a circulatory anti-cardiolipin antibody, psychiatric symptoms, and shortening of fingers and toes, and we discuss about the therapy and review the existing literature.
Case Reports
A 24-year-old man was admitted to Akita University Hospital because of psychiatric problems, livedo racemosa, and shortening of his fingers and toes on January 12, 1995. He had been suffering from facial erythema and frostbite of the extremities since he was one year old. Atthe age of seven andnine, he was admitted to the pediatric department of our hospital due to livedo on his extremities and trunk, and facial erythema. Laboratory tests revealed a high level of erythrocyte sedimentation rate, hypergammaglobulinemia, and a low titer of antinuclear antibody. A skin biopsy of the livedo lesion revealed a constricted artery occluded with cellular and humoral components, a thickened endothelium, and small round cells which had infiltrated around the vessels (Fig. 1 ) . Physical examination and laboratory data of patient and his mother denied congenital Fig. 2 . Although his family history revealed that his mother has been treated for schizophrenia, her cerebral MRIwas normal and anti-cardiolipin antibody was negative. His grandfather had hypertension and dementia. A physical examination showed a deformity of the auricles and shortness and deformity of the fingers and toes (Fig. 3) . X-ray films of the hands showed phalangeal tuftal resorption, which is similar to the finding of progressive systemic sclerosis (PSS). The lungs, heart and abdomen appeared normal. The right patellar reflex has disappeared and a tremor of both arms was observed. Psychological tests revealed a mild mental retardation. Laboratory tests disclosed that the erythrocyte sedimentation rate was 35 mm/hr, the antinuclear antibody was 80 fold, and the anti-cardiolipin antibody (IgG-class) was 1. Psychiatric Disturbance in Sneddon's Syndrome diagnosis of Sneddon's syndrome, due to the multiple cerebral infarction and cerebral atrophy which manifested as a psychiatric disturbance, in addition to livedo racemosa which was detected by a skin biopsy on his previous admission. The patient was then given an intravenous treatment of cyclophosphamide twice (400 mg/day, biweekly), 20 mg/day of prednisolone orally, and 60 |ag/day of prostaglandin I2 analogue orally. His physical symptoms gradually improved and the titer of anticardiolipin antibody (IgG-class) decreased to below 1.0 U/ml. However, a low dose of haloperidol (1-2 mg/day) is still necessary to maintain his mental condition.
Discussion
The combination of livedo racemosaand cerebrovascular disease is knownas Sneddon's syndrome (4). Sneddon commented that the essential feature of this disease is endoarteritis obliterans. Recently, Zelger et al ( 1 1) demonstrated pathological changes in the cutaneous vascular lesions. They studied 15 cases of Sneddon's syndrome and divided the disease into four stages: the initial phase (endothelitis), the early phase (complete arterial occlusion by a sponge-like plug of mononuclear cells), the intermediate phase (subendothelial cell proliferation), and the late phase (distortion and splitting of the lamina elastica interna). In the present case, the skin biopsy specimen, performed when he was fourteen, revealed both the early and intermediate phases of Sneddon' s syndrome. The shortening of the fingers and toes, shown by phalangeal tuftal resorption on X-ray studies, would relate to these findings of small arteries. Regarding the pathogenesis of this disease, Jonas et al (12) suggested the important role of anti-phospholipid antibodies.
Subsequently, this syndrome has come to be thought as a variant of primary anti-phospholipid antibody syndromes.
However, the percentage of anti-cardiolipin antibody or lupus anticoagulant varies between 20% and 60% (5, 6) . Patients with neither anticardiolipin antibody nor lupus anticoagulant have also been observed. The present patient has IgG-class anticardiolipin antibody, which suggests a variant type of antiphospholipid antibody syndrome. As for other factors on the progression of the endothelitis or endoarteritis, Otoyamaet al (8) demonstrated that the serum of such patients reacts with ethanol-fixed endothelial cells, keratinocytes and peripheral blood neutrophils. A further study will clarify the pathogenesis of Sneddon's syndrome. Although more than one hundred cases have been reported in the world, wecould find only three previous cases reported in Japan (8) (9) (10) . Wesummarize four Japanese cases including our own (Table 1 ).
There are three unique points in the clinical course of the present patient. The first was the fact that the initial symptoms occurred as early as only one year old. At the age of9, the skin lesions were already compatible with the early or initial phase of Sneddon' s syndrome. The average age of patients diagnosed as Sneddon's syndrome is 42 years; the present case is the youngest reported in the literature. The second point was the shortening of his fingers and toes (phalangeal resorption), which is sometimes observed in patients with progressive systemic sclerosis (PSS). However, even though he complained of Raynaud's phenomenon and frostbite, there were no signs of proximal skin sclerosis, pulmonary fibrosis, and esophageal dilatation; the lack of antibodies to scl-70 or centromere or nRNPruled out the possibility ofPSS or mixed connective tissue disease. The third point was that psychiatric problems were the predominant clinical manifestations ofcerebrovascular lesions. He did not have a transient ischemic attack or hemiparesis due to the occlusion of the small or medium-sized arteries, which are frequent signs of Sneddon's syndrome. The size of the (5) showed that azathioprine did not prevent further cerebrovascular damageand they speculated that immunosuppressive therapy is of limited value to patients without anti-cardiolipin antibody. In the present case, we administrated 400 mg/day of cyclophosphamide intravenously biweekly in addition to 20 mg/day of prednisolone in order to diminish the titer of IgG-class anti-cardiolipin antibody, which might be a major cause of thrombosis. Wealso administrated 60 jug/day of prostaglandin I2 analogue to prevent contact between the endothelial cells and blood cells. A low dose of haloperidole (2-3 mg/day) in combination with an anti-Parkinson drug was used to alleviate the psychotic symptoms. After the therapy, the anticardiolipin antibody returned to normal, and the psychotic problems disappeared. However, his mental ability remained subnormal and 1-2 mg/day of haloperidole is necessary to prevent a reappearance of psychotic symptoms. A complete evaluation of the present therapy was difficult in this situation. A further controlled study is necessary to determine when and what type of therapy to start. Dermatologists, neurologists, psychiatrists, and rheumatologists should be aware of the importance of Sneddon's syndrome since it can often be an unrecognized, slowly progressive systemic disease caused by endoarteritis.
